Related Experiment Video
Updated: Jun 13, 2026

TAPE: A Biodegradable Hemostatic Glue Inspired by a Ubiquitous Compound in Plants for Surgical Application
Published on: June 8, 2016
FloSeal hemostatic matrix in persistent epistaxis: prospective clinical trial
David Côté1, Brittany Barber, Chris Diamond
1Department of Otolaryngology-Head and Neck Surgery, University of Alberta, Edmonton, Alberta. cote@ualberta.ca
FloSeal hemostatic matrix effectively treated 80% of severe epistaxis cases refractory to nasal packing. This approach avoids surgery, offering a less invasive and potentially cost-effective alternative for managing persistent nasal hemorrhage.
Area of Science:
- Otolaryngology
- Medical Devices
- Surgical Innovation
Background:
- Epistaxis (nosebleeds) can lead to significant hemorrhage requiring intervention.
- Endoscopic ligation surgery is the standard for severe epistaxis unresponsive to conservative measures.
- Surgical ligation demands resources and patient suitability for anesthesia.
Purpose of the Study:
- To evaluate the efficacy of FloSeal hemostatic matrix for epistaxis refractory to nasal packing.
- To determine if FloSeal can serve as an alternative to surgery for persistent nasal hemorrhage.
Main Methods:
- Prospective clinical trial involving patients with epistaxis despite adequate nasal packing.
- Intranasal application of FloSeal hemostatic matrix to control bleeding.
- Patients proceeded to surgical clipping if FloSeal treatment failed.
Main Results:
- FloSeal hemostatic matrix achieved significant success in 80% of patients.
- This avoided the need for surgical intervention in the majority of cases.
- Patients managed with FloSeal were discharged similarly to those undergoing surgery.
Conclusions:
- FloSeal hemostatic matrix is a highly effective tool for managing persistent epistaxis.
- Its ease of use, reduced patient morbidity, and cost-effectiveness suggest a potential practice change.
- This hemostatic matrix offers a valuable alternative in otolaryngology for severe nosebleeds.
Related Concept Videos
Epistaxis
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
Clot Retraction and Fibrinolysis
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
